Results
4094
Companies which are more than 50% undervalued based on analyst price target.
4,094 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
APVO | US$4.31 | -3.4% | -98.2% | US$2.1m | US$21.00 | PB0.5x | E33.5% | n/a | Pharmaceuticals & Biotech | ||
LGMK | US$0.97 | -18.2% | -96.1% | US$2.0m | US$4.00 | PS0.2x | n/a | n/a | Healthcare | ||
PO1 | €1.72 | 1.2% | -69.3% | €1.9m | €6.40 | n/a | n/a | n/a | Media | ||
ALDBT | €0.38 | 7.6% | -93.3% | €1.9m | €3.10 | PS0.1x | E19.2% | n/a | Capital Goods | ||
LPGO | SEK 0.14 | -20.9% | -68.8% | SEK 20.7m | SEK 0.90 | PS2.3x | E139.5% | n/a | Pharmaceuticals & Biotech | ||
ALRPD | €0.021 | -18.0% | -76.1% | €1.8m | €1.00 | PS2.3x | n/a | n/a | Household | ||
AVGR | US$0.39 | -34.8% | -85.6% | US$1.8m | US$5.00 | PS0.2x | E25.0% | n/a | Healthcare | ||
REVB | US$4.27 | 11.8% | -90.4% | US$1.8m | US$170.73 | PB0.6x | S68.2% | n/a | Pharmaceuticals & Biotech | ||
CYN | US$0.085 | -74.6% | -99.5% | US$1.8m | US$12.00 | PS17.8x | S214.0% | n/a | Software | ||
TRVN | US$1.84 | 9.1% | -87.1% | US$1.5m | US$5.00 | PS2.9x | E46.2% | n/a | Pharmaceuticals & Biotech | ||
SEAPT | NOK 0.035 | -16.7% | -99.5% | NOK 16.8m | NOK 2.60 | PS0.007x | E80.6% | n/a | Energy | ||
ARR | NOK 0.24 | -12.4% | -95.0% | NOK 16.8m | NOK 6.00 | PS0.03x | E57.4% | n/a | Software | ||
VRPX | US$0.27 | -12.8% | -92.7% | US$1.4m | US$3.00 | PE-0.1x | E31.1% | n/a | Pharmaceuticals & Biotech | ||
RBGP | UK£0.0089 | 0% | -90.9% | UK£1.1m | UK£0.094 | PS0.03x | S9.7% | 0% | Commercial Services | ||
BONEH | €0.052 | -13.6% | -89.9% | €1.3m | €0.08 | PB0.3x | E25.7% | n/a | Pharmaceuticals & Biotech | ||
TEST.H | CA$0.075 | 0% | n/a | CA$1.7m | CA$37.73 | PB6.7x | n/a | n/a | Tech | ||
TH1NG | SEK 0.50 | -5.7% | -59.7% | SEK 13.5m | SEK 2.20 | PS0.5x | S30.4% | n/a | Telecom | ||
SXTP | US$0.53 | -33.9% | -84.4% | US$1.2m | US$3.40 | PS2.6x | E-1.1% | n/a | Pharmaceuticals & Biotech | ||
SCPX | US$0.25 | -12.3% | -99.7% | US$1.2m | US$5.00 | PS0.1x | E75.2% | n/a | Pharmaceuticals & Biotech | ||
LFLY | US$0.30 | -9.1% | -91.6% | US$1.1m | US$7.59 | PS0.03x | S-2.4% | n/a | Media | ||
MQM | CA$0.06 | 0% | -14.3% | CA$1.6m | CA$0.72 | PB3.1x | n/a | n/a | Materials | ||
SCOL | SEK 0.051 | -24.6% | -98.3% | SEK 11.7m | SEK 0.26 | PB0.3x | E69.7% | n/a | Pharmaceuticals & Biotech | ||
NMHI | US$0.38 | -16.6% | -99.9% | US$989.4k | US$21.00 | PS0.1x | E65.5% | n/a | Capital Goods | ||
ZWIPE | NOK 0.04 | -7.0% | -90.6% | NOK 11.1m | NOK 3.00 | PS16.9x | S115.3% | n/a | Tech |